AI Science Tracker

KAIST

1 discovery from 2026

Discoveries

AI-designed protein family binds and senses small molecules, including cortisol

The study combines trRosetta-based scaffold hallucination and Rosetta design with ProteinMPNN/LigandMPNN sequence design and AlphaFold structural filtering to create NTF2-like binders for six small-molecule targets. An optimized cortisol binder had a measured dissociation constant of 68 nM. A purified-protein, split-luciferase cortisol sensor showed an estimated response EC50 of 72 nM; this is a sensor response measurement, not the binding-affinity value or a clinical detection limit. The sensor also responded to cortisone and 17-alpha-hydroxyprogesterone, so specificity needs improvement. The March 2026 peer-reviewed paper is the source of record.

Technology: trRosetta-based hallucination; Rosetta; ProteinMPNN/LigandMPNN sequence design; AlphaFold structural filtering

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Designed binders for six small-molecule targets were measured for binding affinity (nanomolar to low micromolar), and a cortisol binder was used to build a biosensor.
  • Still unknown: The abstract states no specific limitations.
  • AI role: Deep learning combined with physics-based methods generated a protein family with varied designable pocket geometries.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41467-026-70953-8&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.